Position in EVO
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$70
New position
Shares Held
25
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#32
of 34 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Silver Grove Financial Group, Inc. holds $324,636 across 30 Drug Manufacturers - Specialty & Generic names. EVO ranks #29 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
1,169 | $84,004 | |
| 2 | HLN |
Haleon plc
|
6,003 | $56,007 | |
| 3 | LNTH |
Lantheus Holdings, Inc.
|
344 | $38,163 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
53 | $28,716 | |
| 5 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
307 | $19,632 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
|
84 | $14,157 | |
| 7 | TAK |
Takeda Pharmaceutical Co Ltd
|
883 | $14,154 | |
| 8 | BHC |
Bausch Health Companies Inc.
|
2,249 | $11,087 |
All Filings in EVO
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $70 | 25 | Shares | Sole | 2026-08-13 | |
| No filing history on record for this holder in this stock. | ||||||